Research Nester has recently announced the addition of the on “Global Liquid Biopsy Market Analysis & Opportunity Outlook 2021”, which aims at providing detailed market evaluation on demand, supply, growth & opportunity. The research dives deep into the market trends and provides an in-depth and thorough vision of the business environment for the liquid biopsy market. Further, after studying the market situation and anticipating the future trends, the research provides a concrete platform for the existing and new players looking to enter into the market. The study provides information about market scenario of forecast period by analyzing the current situation.

Get Free Full Table Of Content :
http://www.researchnester.com/toc-request/1/rep-id-69

Liquid biopsy is a non-invasive and simple alternative of conventional surgical biopsies that enable medical professionals to detect cancer causing tumours just by taking the blood sample of the patient. In this manner, liquid biopsy assists the doctors in selecting the correct treatment procedure for patients at right time.

The global liquid biopsy market is anticipated to witness a substantial compound annual growth rate (CAGR) of 25.0% from 2016 to reach USD 10, 850 Million by 2021. Regionally, the global liquid biopsy market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific, Middle East and North Africa (MENA) and Rest of World (Row).

Growth Drivers and challenges
Rising number of cancer patients in the world coupled with innovation in liquid biopsy technology is anticipated to drive the global liquid biopsy market over the forecast period.
In addition to that rising government initiatives to create awareness about cancer detection and treatments is also expected to bolster the global liquid biopsy market in future.

However, expensive medical procedures & cost intensive research process involved in liquid biopsy is anticipated to restrain the development of the global liquid biopsy market over next few years.

Market Size and Forecast
Regionally, North America dominates the global liquid biopsy market. It is projected that by 2016 end, 1.7 million new cancer cases would be detected in the U.S. alone, making the country a major market for liquid biopsy in North America.

Western Europe liquid biopsy market is also expected to witness a promising growth sparked by rising cases of lung cancer, which is responsible for 21.5 %of all cancer mortalities in the European region.
Asia-Pacific liquid biopsy market is likely to behold the highest CAGR during the forecast period i.e. 2015-2021. Rising per capita income and increasing investments on healthcare infrastructure are some of the major factors which are projected to bolster liquid biopsy market in countries such as India and China.

Contact Key extracts from the Table of Content of Liquid biopsy Market 2016-2021 report:
Liquid biopsy Market Size and Forecast, 2016-2021
Liquid biopsy Market CAGR for the Period 2016-2021
Liquid biopsy Market Y-O-Y for the Period 2016-2021
Liquid biopsy Market Demand & Supply Analysis
Liquid biopsy Market Investment Attractiveness
Liquid biopsy Market BPS Analysis
Liquid biopsy Market Dynamics – Trends, Drivers, Challenges, and Opportunities
Liquid biopsy Market Competitive Landscape Analysis
Liquid biopsy Market Investment Proposition, by Geography


To know more about the research, Source:
http://www.researchnester.com/reports/global-liquid-biopsy-market-analysis-opportunity-outlook-2021/69

contact us

Ajay Daniel
Email: [email protected]
Phone : U.S. +1 646 586 9123
U.K. +44 203 608 5919
web:www.researchnester.com